Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gastrointestinal Cancer

Breast Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Gastrointestinal Cancer

Immunotherapy Combo Shows Signs of Efficacy in 2 HCC Settings

Using dual checkpoint inhibitors in patients with hepatocellular carcinoma is demonstrating activity with a manageable safety profile in both second-line and perioperative settings.
Read More >>

Atezolizumab/Bevacizumab Combo Improves Survival in Frontline HCC

Advances in Small Bowel Cancer Generate New NCCN Guidelines

Chemotherapy Triplet Elicits Encouraging Activity in Pancreatic Adenocarcinoma

Pegilodecakin Falls Short in Phase III Pancreatic Cancer Trial

TAS-102 Effective in Gastric/GEJ Cancer, Regardless of Prior Gastrectomy

View More Stories >>

View Conference Coverage

2019 Hairy Cell Leukemia Foundation Annual Conference

2019 Lynn Sage Breast Cancer Symposium

2019 ESMO Congress

17th International Myeloma Workshop

2019 Society of Hematologic Oncology Annual Meeting

Dr. Benson on the Use of Genomic Testing in Newly Diagnosed mCRC

Dr. Richards on Genetic Testing in Metastatic Pancreatic Cancer

Dr. Weinberg on Targeted Therapies for Molecular Subsets of mCRC

Dr. Lee on Trial Data Evaluating the Atezolizumab/Bevacizumab in Unresectable HCC

Dr. Shroff on Genomic Landscape of Cholangiocarcinoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Tumor Markers in CCA

Heterogeneity of CCA

Diagnosing CCA

Any Role for Immunotherapy in Pancreatic Cancer?

The Role of Immunotherapy in Treating R/R mHCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

The Future of Personalized Therapy in Advanced HCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma

Andrew Ko, MD, professor, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, provides insight on PEGPH20 for patients with pancreatic adenocarcinoma. View Now

Sequencing Decisions in Gastroesophageal Cancers

Led by Johanna Bendell, MD, panelists Ian Chau, MD; Yelena Y. Janjigian, MD; Manish A. Shah, MD; and Kohei Shitara, MD, focus on sequencing decisions for patients with gastroesophageal cancers. View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval in Myeloma, Label Update in HER2+ Breast Cancer, Breakthrough Status in Prostate Cancer, and More